Pricing Log in Create free account

Cullinan Therapeutics, Inc. (CGEM) vs MoonLake Immunotherapeutics (MLTX)

Cullinan Therapeutics, Inc. and MoonLake Immunotherapeutics are both Biotechnology companies. Cullinan Therapeutics, Inc. and MoonLake Immunotherapeutics are of similar size ($901.0M and $873.2M). Across the 9 metrics below, Cullinan Therapeutics, Inc. leads on 6 and MoonLake Immunotherapeutics on 3.

Valuation

Metric CGEM MLTX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.47 1.65 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (23.98%) (40.21%) (33.15%)
Free cash flow yield (20.03%) (31.91%) (25.50%)

Profitability

Metric CGEM MLTX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.30%) (67.08%) (56.36%)
Return on assets (46.30%) (51.00%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CGEM MLTX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (20.86%) (86.77%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGEM MLTX Biotechnology median
Debt to equity 0.00 0.23 0.00
Current ratio 8.42 12.56 4.72
Net debt to EBITDA 1.57 1.32 0.96

Dividend

Metric CGEM MLTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CGEM MLTX Biotechnology median
Market cap 900.97m 873.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack